⌕
Dr. Reddy's Laboratories · RDY · NYSE
Tenet 45 · Mixed
Compare
$14.79+0.61%At closeTenet 45 · Mixed
$14.79+0.09 (+0.61%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Dr. Reddy's Laboratories (RDY) Stock

Dr. Reddy's Laboratories (RDY) closed at $14.79 on Nov 17, 2026; its Tenet Score is 45 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

22 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$14.79
Nov 17, 2026
Market cap
$12.3B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
27.1×
fiscal year to Mar 31, 2026 · as of close, Nov 16, 2026
Dividend yield
0.57%
past year's regular dividends ÷ price · as of close, Nov 16, 2026
52-week range
11.36 – 15.67
low → high · as of close, Nov 16, 2026
Tenet Score
45/100
Mixed · 340 Healthcare peers

Industry: Drugs

Dr. Reddy's Laboratories Ltd. scores 45/100. Mixed. Growth is the soft spot, trading at 27× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
45/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
49
Quality
57
Health
48
Growth
24

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityCHealthDGrowthFMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
3.1×
fiscal year to Mar 31, 2026 · as of close, Nov 16, 2026
P/S
3.4×
price to sales, fiscal 2026 · as of close, Nov 16, 2026
ROE
23%
fiscal year to Mar 31, 2026
Operating margin
15.1%
before interest and tax
Net margin
12.6%
fiscal year to Mar 31, 2026
Current ratio
1.80
fiscal year to Mar 31, 2026
Net debt / EBITDA
−0.2×
fiscal year to Mar 31, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segmen…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 25 US ETFs · top wrappers by weightSee all ETFs holding RDY →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Dr. Reddy's Laboratories in?

Dr. Reddy's Laboratories is in the Healthcare sector and the Drugs industry.

What is Dr. Reddy's Laboratories' Tenet Score?

Dr. Reddy's Laboratories' Tenet Score is 45 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.